Skip to main content
Erschienen in: Pediatric Surgery International 1/2023

01.12.2023 | Comment

Translational research in Hirschprung’s disease at the National Children’s Research Centre in Dublin

verfasst von: Anne Marie O’Donnell

Erschienen in: Pediatric Surgery International | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Abstract

Hirschsprung’s disease (HD) is a congenital condition characterised by aganglionosis in the distal bowel. Over the years, at the National Children’s Research Centre (NCRC), HD has been one of the most prominent and successful research areas for Prof. Prem Puri’s research team. Research fellows from around the world came to the NCRC to work on both animal and human studies of HD and, cumulatively, made important discoveries in this field, publishing a total of 144 HD articles in peer-reviewed journals. Through their published work, the NCRC has been recognised as the leading international centre for the investigation of HD and its allied disorders. In this review, I will summarise the main findings from this work.
Literatur
1.
Zurück zum Zitat Gosain A et al (2017) Guidelines for the diagnosis and management of Hirschsprung-associated enterocolitis. Pediatr Surg Int 33(5):517–521PubMedPubMedCentral Gosain A et al (2017) Guidelines for the diagnosis and management of Hirschsprung-associated enterocolitis. Pediatr Surg Int 33(5):517–521PubMedPubMedCentral
2.
Zurück zum Zitat Fujimoto T, Reen DJ, Puri P (1988) Inflammatory response in enterocolitis in the piebald lethal mouse model of Hirschsprung’s disease. Pediatr Res 24(2):152–155PubMed Fujimoto T, Reen DJ, Puri P (1988) Inflammatory response in enterocolitis in the piebald lethal mouse model of Hirschsprung’s disease. Pediatr Res 24(2):152–155PubMed
3.
Zurück zum Zitat Imamura A et al (1992) Mucosal immune defence mechanisms in enterocolitis complicating Hirschsprung’s disease. Gut 33(6):801–806PubMedPubMedCentral Imamura A et al (1992) Mucosal immune defence mechanisms in enterocolitis complicating Hirschsprung’s disease. Gut 33(6):801–806PubMedPubMedCentral
4.
Zurück zum Zitat Soeda J, O’Briain DS, Puri P (1992) Mucosal neuroendocrine cell abnormalities in the colon of patients with Hirschsprung’s disease. J Pediatr Surg 27(7):823–827PubMed Soeda J, O’Briain DS, Puri P (1992) Mucosal neuroendocrine cell abnormalities in the colon of patients with Hirschsprung’s disease. J Pediatr Surg 27(7):823–827PubMed
5.
Zurück zum Zitat Nemeth L et al (2001) Three-dimensional morphology of gut innervation in total intestinal aganglionosis using whole-mount preparation. J Pediatr Surg 36(2):291–295PubMed Nemeth L et al (2001) Three-dimensional morphology of gut innervation in total intestinal aganglionosis using whole-mount preparation. J Pediatr Surg 36(2):291–295PubMed
6.
Zurück zum Zitat Kobayashi H et al (1995) Intraoperative evaluation of extent of aganglionosis by a rapid acetylcholinesterase histochemical technique. J Pediatr Surg 30(2):248–252PubMed Kobayashi H et al (1995) Intraoperative evaluation of extent of aganglionosis by a rapid acetylcholinesterase histochemical technique. J Pediatr Surg 30(2):248–252PubMed
7.
Zurück zum Zitat Kusafuka T, Puri P (1997) Altered mRNA expression of the neuronal nitric oxide synthase gene in Hirschsprung’s disease. J Pediatr Surg 32(7):1054–1058PubMed Kusafuka T, Puri P (1997) Altered mRNA expression of the neuronal nitric oxide synthase gene in Hirschsprung’s disease. J Pediatr Surg 32(7):1054–1058PubMed
8.
Zurück zum Zitat Kusafuka T, Puri P (1997) Altered RET gene mRNA expression in Hirschsprung’s disease. J Pediatr Surg 32(4):600–604PubMed Kusafuka T, Puri P (1997) Altered RET gene mRNA expression in Hirschsprung’s disease. J Pediatr Surg 32(4):600–604PubMed
9.
Zurück zum Zitat Kusafuka T, Puri P (1997) Mutations of the endothelin-B receptor and endothelin-3 genes in Hirschsprung’s disease. Pediatr Surg Int 12(1):19–23PubMed Kusafuka T, Puri P (1997) Mutations of the endothelin-B receptor and endothelin-3 genes in Hirschsprung’s disease. Pediatr Surg Int 12(1):19–23PubMed
10.
Zurück zum Zitat Wester T, O’Briain DS, Puri P (1999) Notable postnatal alterations in the myenteric plexus of normal human bowel. Gut 44(5):666–674PubMedPubMedCentral Wester T, O’Briain DS, Puri P (1999) Notable postnatal alterations in the myenteric plexus of normal human bowel. Gut 44(5):666–674PubMedPubMedCentral
11.
Zurück zum Zitat Wester T, O’Briain S, Puri P (1998) Morphometric aspects of the submucous plexus in whole-mount preparations of normal human distal colon. J Pediatr Surg 33(4):619–622PubMed Wester T, O’Briain S, Puri P (1998) Morphometric aspects of the submucous plexus in whole-mount preparations of normal human distal colon. J Pediatr Surg 33(4):619–622PubMed
12.
Zurück zum Zitat Wester T, O’Briain S, Puri P (1998) NADPH diaphorase-containing nerve fibers and neurons in the myenteric plexus are resistant to postmortem changes: studies in Hirschsprung’s disease and normal autopsy material. Arch Pathol Lab Med 122(5):461–466PubMed Wester T, O’Briain S, Puri P (1998) NADPH diaphorase-containing nerve fibers and neurons in the myenteric plexus are resistant to postmortem changes: studies in Hirschsprung’s disease and normal autopsy material. Arch Pathol Lab Med 122(5):461–466PubMed
13.
Zurück zum Zitat Cserni T, Paran S, Puri P (2007) The effect of age on colocalization of acetylcholinesterase and nicotinamide adenine dinucleotide phosphate diaphorase staining in enteric neurons in an experimental model. J Pediatr Surg 42(2):300–304PubMed Cserni T, Paran S, Puri P (2007) The effect of age on colocalization of acetylcholinesterase and nicotinamide adenine dinucleotide phosphate diaphorase staining in enteric neurons in an experimental model. J Pediatr Surg 42(2):300–304PubMed
14.
Zurück zum Zitat Cserni T et al (2009) Correlation of enteric NADPH-d positive cell counts with the duration of incubation period in NADPH-d histochemistry. Pathol Oncol Res 15(1):103–107PubMed Cserni T et al (2009) Correlation of enteric NADPH-d positive cell counts with the duration of incubation period in NADPH-d histochemistry. Pathol Oncol Res 15(1):103–107PubMed
15.
Zurück zum Zitat Nemeth L, Maddur S, Puri P (2000) Immunolocalization of the gap junction protein Connexin43 in the interstitial cells of Cajal in the normal and Hirschsprung’s disease bowel. J Pediatr Surg 35(6):823–828PubMed Nemeth L, Maddur S, Puri P (2000) Immunolocalization of the gap junction protein Connexin43 in the interstitial cells of Cajal in the normal and Hirschsprung’s disease bowel. J Pediatr Surg 35(6):823–828PubMed
16.
Zurück zum Zitat Oue T et al (2000) Muscarinic acetylcholine receptor expression in aganglionic bowel. Pediatr Surg Int 16(4):267–271PubMed Oue T et al (2000) Muscarinic acetylcholine receptor expression in aganglionic bowel. Pediatr Surg Int 16(4):267–271PubMed
17.
Zurück zum Zitat Yoneda A et al (2001) Cell-adhesion molecules and fibroblast growth factor signalling in Hirschsprung’s disease. Pediatr Surg Int 17(4):299–303PubMed Yoneda A et al (2001) Cell-adhesion molecules and fibroblast growth factor signalling in Hirschsprung’s disease. Pediatr Surg Int 17(4):299–303PubMed
18.
Zurück zum Zitat Rolle U et al (2002) Altered distribution of interstitial cells of Cajal in Hirschsprung disease. Arch Pathol Lab Med 126(8):928–933PubMed Rolle U et al (2002) Altered distribution of interstitial cells of Cajal in Hirschsprung disease. Arch Pathol Lab Med 126(8):928–933PubMed
19.
Zurück zum Zitat Menezes M, Puri P (2005) Long-term clinical outcome in patients with Hirschsprung’s disease and associated Down’s syndrome. J Pediatr Surg 40(5):810–812PubMed Menezes M, Puri P (2005) Long-term clinical outcome in patients with Hirschsprung’s disease and associated Down’s syndrome. J Pediatr Surg 40(5):810–812PubMed
20.
Zurück zum Zitat Menezes M, Corbally M, Puri P (2006) Long-term results of bowel function after treatment for Hirschsprung’s disease: a 29-year review. Pediatr Surg Int 22(12):987–990PubMed Menezes M, Corbally M, Puri P (2006) Long-term results of bowel function after treatment for Hirschsprung’s disease: a 29-year review. Pediatr Surg Int 22(12):987–990PubMed
21.
Zurück zum Zitat Menezes M et al (2008) Long-term clinical outcome in patients with total colonic aganglionosis: a 31-year review. J Pediatr Surg 43(9):1696–1699PubMed Menezes M et al (2008) Long-term clinical outcome in patients with total colonic aganglionosis: a 31-year review. J Pediatr Surg 43(9):1696–1699PubMed
22.
Zurück zum Zitat Menezes M, Puri P (2006) Long-term outcome of patients with enterocolitis complicating Hirschsprung’s disease. Pediatr Surg Int 22(4):316–318PubMed Menezes M, Puri P (2006) Long-term outcome of patients with enterocolitis complicating Hirschsprung’s disease. Pediatr Surg Int 22(4):316–318PubMed
23.
Zurück zum Zitat Coyle D et al (2019) The extent of the transition zone in hirschsprung disease. J Pediatr Surg 54(11):2318–2324PubMed Coyle D et al (2019) The extent of the transition zone in hirschsprung disease. J Pediatr Surg 54(11):2318–2324PubMed
24.
Zurück zum Zitat O’Donnell AM, Coyle D, Puri P (2016) Deficiency of platelet-derived growth factor receptor-alpha-positive cells in Hirschsprung’s disease colon. World J Gastroenterol 22(12):3335–3340PubMedPubMedCentral O’Donnell AM, Coyle D, Puri P (2016) Deficiency of platelet-derived growth factor receptor-alpha-positive cells in Hirschsprung’s disease colon. World J Gastroenterol 22(12):3335–3340PubMedPubMedCentral
25.
Zurück zum Zitat O’Donnell AM, Nakamura H, Puri P (2020) Tuft cells: a new player in Hirschsprung’s disease. Eur J Pediatr Surg 30(1):59–63PubMed O’Donnell AM, Nakamura H, Puri P (2020) Tuft cells: a new player in Hirschsprung’s disease. Eur J Pediatr Surg 30(1):59–63PubMed
26.
Zurück zum Zitat Nakamura H et al (2018) Altered goblet cell function in Hirschsprung’s disease. Pediatr Surg Int 34(2):121–128PubMed Nakamura H et al (2018) Altered goblet cell function in Hirschsprung’s disease. Pediatr Surg Int 34(2):121–128PubMed
27.
Zurück zum Zitat Coyle D et al (2016) Altered neurotransmitter expression profile in the ganglionic bowel in Hirschsprung’s disease. J Pediatr Surg 51(5):762–769PubMed Coyle D et al (2016) Altered neurotransmitter expression profile in the ganglionic bowel in Hirschsprung’s disease. J Pediatr Surg 51(5):762–769PubMed
28.
Zurück zum Zitat Piotrowska AP, Solari V, Puri P (2003) Distribution of Ca2+-activated K channels, SK2 and SK3, in the normal and Hirschsprung’s disease bowel. J Pediatr Surg 38(6):978–983PubMed Piotrowska AP, Solari V, Puri P (2003) Distribution of Ca2+-activated K channels, SK2 and SK3, in the normal and Hirschsprung’s disease bowel. J Pediatr Surg 38(6):978–983PubMed
29.
Zurück zum Zitat O’Donnell AM, Coyle D, Puri P (2015) Decreased expression of hyperpolarisation-activated cyclic nucleotide-gated channel 3 in Hirschsprung’s disease. World J Gastroenterol 21(18):5635–5640PubMedPubMedCentral O’Donnell AM, Coyle D, Puri P (2015) Decreased expression of hyperpolarisation-activated cyclic nucleotide-gated channel 3 in Hirschsprung’s disease. World J Gastroenterol 21(18):5635–5640PubMedPubMedCentral
30.
Zurück zum Zitat O’Donnell AM, Coyle D, Puri P (2016) Decreased Nav1.9 channel expression in Hirschsprung’s disease. J Pediatr Surg 51(9):1458–1461PubMed O’Donnell AM, Coyle D, Puri P (2016) Decreased Nav1.9 channel expression in Hirschsprung’s disease. J Pediatr Surg 51(9):1458–1461PubMed
31.
Zurück zum Zitat O’Donnell AM, Coyle D, Puri P (2017) Decreased expression of Kv7 channels in Hirchsprung’s disease. J Pediatr Surg 52(7):1177–1181PubMed O’Donnell AM, Coyle D, Puri P (2017) Decreased expression of Kv7 channels in Hirchsprung’s disease. J Pediatr Surg 52(7):1177–1181PubMed
32.
Zurück zum Zitat O’Donnell AM et al (2019) Decreased expression of TRAAK channels in Hirschsprung’s disease: a possible cause of postoperative dysmotility. Pediatr Surg Int 35(12):1431–1435PubMed O’Donnell AM et al (2019) Decreased expression of TRAAK channels in Hirschsprung’s disease: a possible cause of postoperative dysmotility. Pediatr Surg Int 35(12):1431–1435PubMed
33.
Zurück zum Zitat Coyle D et al (2016) Use of anoctamin 1 (ANO1) to evaluate interstitial cells of Cajal in Hirschsprung’s disease. Pediatr Surg Int 32(2):125–133PubMed Coyle D et al (2016) Use of anoctamin 1 (ANO1) to evaluate interstitial cells of Cajal in Hirschsprung’s disease. Pediatr Surg Int 32(2):125–133PubMed
34.
Zurück zum Zitat Coyle D, O’Donnell AM, Puri P (2015) Altered distribution of small-conductance calcium-activated potassium channel SK3 in Hirschsprung’s disease. J Pediatr Surg 50(10):1659–1664PubMed Coyle D, O’Donnell AM, Puri P (2015) Altered distribution of small-conductance calcium-activated potassium channel SK3 in Hirschsprung’s disease. J Pediatr Surg 50(10):1659–1664PubMed
35.
Zurück zum Zitat Coyle D et al (2015) Rho-kinase expression in Hirschsprung’s disease. Pediatr Surg Int 31(11):1077–1085PubMed Coyle D et al (2015) Rho-kinase expression in Hirschsprung’s disease. Pediatr Surg Int 31(11):1077–1085PubMed
36.
Zurück zum Zitat Tomuschat C et al (2016) Altered expression of a two-pore domain (K2P) mechano-gated potassium channel TREK-1 in Hirschsprung’s disease. Pediatr Res 80(5):729–733PubMed Tomuschat C et al (2016) Altered expression of a two-pore domain (K2P) mechano-gated potassium channel TREK-1 in Hirschsprung’s disease. Pediatr Res 80(5):729–733PubMed
37.
Zurück zum Zitat Tomuschat C et al (2016) Altered expression of ATP-sensitive K(+) channels in Hirschsprung’s disease. J Pediatr Surg 51(6):948–952PubMed Tomuschat C et al (2016) Altered expression of ATP-sensitive K(+) channels in Hirschsprung’s disease. J Pediatr Surg 51(6):948–952PubMed
38.
Zurück zum Zitat Puri P, Gosemann JH (2012) Variants of Hirschsprung disease. Semin Pediatr Surg 21(4):310–318PubMed Puri P, Gosemann JH (2012) Variants of Hirschsprung disease. Semin Pediatr Surg 21(4):310–318PubMed
39.
Zurück zum Zitat Friedmacher F, Puri P (2013) Classification and diagnostic criteria of variants of Hirschsprung’s disease. Pediatr Surg Int 29(9):855–872PubMed Friedmacher F, Puri P (2013) Classification and diagnostic criteria of variants of Hirschsprung’s disease. Pediatr Surg Int 29(9):855–872PubMed
40.
Zurück zum Zitat Puri P, Rolle U (2004) Variant Hirschsprung’s disease. Semin Pediatr Surg 13(4):293–299PubMed Puri P, Rolle U (2004) Variant Hirschsprung’s disease. Semin Pediatr Surg 13(4):293–299PubMed
41.
Zurück zum Zitat Puri P, Shinkai T (2004) Pathogenesis of Hirschsprung’s disease and its variants: recent progress. Semin Pediatr Surg 13(1):18–24PubMed Puri P, Shinkai T (2004) Pathogenesis of Hirschsprung’s disease and its variants: recent progress. Semin Pediatr Surg 13(1):18–24PubMed
42.
Zurück zum Zitat Puri P (1997) Variant Hirschsprung’s disease. J Pediatr Surg 32(2):149–157PubMed Puri P (1997) Variant Hirschsprung’s disease. J Pediatr Surg 32(2):149–157PubMed
Metadaten
Titel
Translational research in Hirschprung’s disease at the National Children’s Research Centre in Dublin
verfasst von
Anne Marie O’Donnell
Publikationsdatum
01.12.2023
Verlag
Springer Berlin Heidelberg
Erschienen in
Pediatric Surgery International / Ausgabe 1/2023
Print ISSN: 0179-0358
Elektronische ISSN: 1437-9813
DOI
https://doi.org/10.1007/s00383-022-05323-8

Weitere Artikel der Ausgabe 1/2023

Pediatric Surgery International 1/2023 Zur Ausgabe

Neuer Typ-1-Diabetes bei Kindern am Wochenende eher übersehen

23.04.2024 Typ-1-Diabetes Nachrichten

Wenn Kinder an Werktagen zum Arzt gehen, werden neu auftretender Typ-1-Diabetes und diabetische Ketoazidosen häufiger erkannt als bei Arztbesuchen an Wochenenden oder Feiertagen.

Neue Studienergebnisse zur Myopiekontrolle mit Atropin

22.04.2024 Fehlsichtigkeit Nachrichten

Augentropfen mit niedrig dosiertem Atropin können helfen, das Fortschreiten einer Kurzsichtigkeit bei Kindern zumindest zu verlangsamen, wie die Ergebnisse einer aktuellen Studie mit verschiedenen Dosierungen zeigen.

Spinale Muskelatrophie: Neugeborenen-Screening lohnt sich

18.04.2024 Spinale Muskelatrophien Nachrichten

Seit 2021 ist die Untersuchung auf spinale Muskelatrophie Teil des Neugeborenen-Screenings in Deutschland. Eine Studie liefert weitere Evidenz für den Nutzen der Maßnahme.

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

18.04.2024 Pädiatrische Notfallmedizin Nachrichten

Im Choosing-Wisely-Programm, das für die deutsche Initiative „Klug entscheiden“ Pate gestanden hat, sind erstmals Empfehlungen zum Umgang mit Notfällen von Kindern erschienen. Fünf Dinge gilt es demnach zu vermeiden.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.